Abound Financial’s Merck MRK Stock Holding History

Abound Financial’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$31.6K	Hold	246	–	–	0.01%	151
2026 Q1	$29.6K	Hold	246	–	–	0.01%	148
2025 Q4	$25.9K	Buy	+246	New	+$23.1K	0.01%	156
2025 Q2	–	Sell	-246	Closed	-$22.1K	–	188
2025 Q1	$22.1K	Buy	+246	New	+$23K	0.01%	161

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Abound Financial's MRK Position: Q2 2026 in Review

Abound Financial held its Merck (MRK) position steady in Q2 2026 at 246 shares worth $31.6K. The position accounts for 0.01% of the portfolio, ranked #151.

Abound Financial first reported a position in MRK in Q1 2025 and has held it in 4 quarters since. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Abound Financial held 246 shares of Merck worth $31.6K as of Q2 2026.
Abound Financial left its Merck share count unchanged in Q2 2026.
Merck made up 0.01% of Abound Financial's portfolio in Q2 2026, its #151 holding.
Abound Financial first reported a position in Merck in Q1 2025 and has held it in 4 quarters since.
3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Abound Financial's 13F filing for Q2 2026, filed 14 Aug 2026.